Expertise in Blood and Bone Marrow Transplant (BMT)
The Stanford Blood and Marrow Transplant Program combines 25 years of treatment expertise, state-of-the-art research and comprehensive support services to provide the best possible outcomes. Offering treatment for malignant and non-malignant diseases, including lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected solid tumors, our program strives to integrate each patient into normal, everyday life.
A type of blood cancer in which bone marrow and other lymphatic system organs slowly make too many lymphocytes (a type of white blood cell). The term "chronic" means the disease progresses more slowly.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Maps, directions, parking, public transit options, and contact information
Other patient resources
The initial evaluation process begins with a referral from your hematologist or oncologist to a Stanford Blood and Marrow Transplantation Program doctor. After this referral, the Stanford Blood and Marrow Transplant Program new patient coordinator will call you with an appointment date and time.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
HOW TO REFER
To refer a patient, call our Stanford Blood and Marrow Transplantation Program office at 650-723-0822.
Track your patients' progress and communicate with Stanford providers securely online.